Back

Association of TRI-SCORE with clinical outcomes after percutaneous tricuspid annuloplasty

30 August 2024 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Hot topics in percutaneous mitral and tricuspid valve interventions Tricuspid Valve Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Antonio Piris Sanchez

Ramon and Cajal University Hospital, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail
The prognostic impact of intra-procedural mitral valve gradient following transcatheter edge-to-edge repair for primary mitral regurgitation
Doctor S. Ludwig (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Trans catheter edge to edge repair for mitral regurgitation and left ventricular outflow obstruction in hypertrophic cardiomyopathy
Professor S. Carasso (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Leveraging mixed reality in mitraclip implantation: A preliminary case series toward a pilot study
Mr J. Hecko (Trinec, CZ)
Abstract Slides Video
Presentation thumbnail
One-year outcomes of transcatheter mitral valve replacement in patients with severe mitral regurgitation
Doctor S. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Intra, short and long-term results of mitral VIV for the degenerated surgical mitral prosthesis from italian VIV registry (MIVIV registry)
Doctor E. Zancanaro (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Hot topics in percutaneous mitral and tricuspid valve interventions
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 10:20 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
thumbnail
Congress Presentation
Risk scores: can they determine who should and should not undergo transcatheter interventions?
thumbnail
Congress Presentation
Clinical outcomes according to clinical and surgical risk scores for tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources